131 related articles for article (PubMed ID: 11197078)
1. Time-dependent nephrotoxicity associated with daily administration of cisplatin in mice.
To H; Kikuchi A; Tsuruoka S; Sugimoto K; Fujimura A; Higuchi S; Kayama F; Hara K; Matsuno K; Kobayashi E
J Pharm Pharmacol; 2000 Dec; 52(12):1499-504. PubMed ID: 11197078
[TBL] [Abstract][Full Text] [Related]
2. Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats.
Kobayashi M; To H; Yuzawa M; Hakamata Y; Higuchi S; Tokue A; Fujimura A; Kobayashi E
J Pharm Pharmacol; 2000 Oct; 52(10):1233-7. PubMed ID: 11092567
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
Santos NA; Bezerra CS; Martins NM; Curti C; Bianchi ML; Santos AC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):145-55. PubMed ID: 17396264
[TBL] [Abstract][Full Text] [Related]
5. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
[TBL] [Abstract][Full Text] [Related]
6. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C protects against cisplatin-induced nephrotoxicity and damage without reducing its effectiveness in C57BL/6 mice xenografted with Lewis lung carcinoma.
Chen MF; Yang CM; Su CM; Hu ML
Nutr Cancer; 2014; 66(7):1085-91. PubMed ID: 25157954
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
10. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
[TBL] [Abstract][Full Text] [Related]
11. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.
Domitrović R; Cvijanović O; Pugel EP; Zagorac GB; Mahmutefendić H; Škoda M
Toxicology; 2013 Aug; 310():115-23. PubMed ID: 23770416
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
13. Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods.
Stewart DJ; Dulberg CS; Mikhael NZ; Redmond MD; Montpetit VA; Goel R
Cancer Chemother Pharmacol; 1997; 40(4):293-308. PubMed ID: 9225947
[TBL] [Abstract][Full Text] [Related]
14. Effect of cisplatin on the clock genes expression in the liver, heart and kidney.
Cao BB; Li D; Xing X; Zhao Y; Wu K; Jiang F; Yin W; Li JD
Biochem Biophys Res Commun; 2018 Jun; 501(2):593-597. PubMed ID: 29753739
[TBL] [Abstract][Full Text] [Related]
15. Tiopronin protects against the nephrotoxicity of cisplatin in the rat.
Zhang JG; Viale M; Esposito M; Lindup WE
Hum Exp Toxicol; 1999 Dec; 18(12):713-7. PubMed ID: 10627657
[TBL] [Abstract][Full Text] [Related]
16. Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin.
Sarangarajan R; Cacini W
Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):66-71. PubMed ID: 15379782
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients.
Erdlenbruch B; Nier M; Kern W; Hiddemann W; Pekrun A; Lakomek M
Eur J Clin Pharmacol; 2001 Aug; 57(5):393-402. PubMed ID: 11599657
[TBL] [Abstract][Full Text] [Related]
18. Reduction of cisplatin-induced nephrotoxicity by cystone, a polyherbal ayurvedic preparation, in C57BL/6J mice bearing B16F1 melanoma without reducing its antitumor activity.
Rao M; Praveen Rao PN; Kamath R; Rao MN
J Ethnopharmacol; 1999 Dec; 68(1-3):77-81. PubMed ID: 10624865
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
Lee CK; Son SH; Park KK; Park JH; Lim SS; Kim SH; Chung WY
Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
[TBL] [Abstract][Full Text] [Related]
20. Reduction of cisplatin-induced nephrotoxicity by pyrazolone compounds, derivatives of tetrahydroindazolonedicarboxylic acid.
Marijic VF; Makarevic J; Stojkovic R; Kalinic L; Katalenic D; Radacic M
Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):675-80. PubMed ID: 19229375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
